Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients

PURPOSE: To analyze the clinical features and risk factors of tigecycline-associated hypofibrinogenaemia and study whether cefoperazone/sulbactam combined with tigecycline aggravates coagulopathy or hypofibrinogenaemia. METHODS: A retrospective case–control study of patients with severe infection wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Juan, Xiao, Yong-hong, Zheng, Yi, Lai, Yang-xiao, Fang, Xue-ling, Fang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224009/
https://www.ncbi.nlm.nih.gov/pubmed/32355990
http://dx.doi.org/10.1007/s00228-020-02860-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224009/
https://www.ncbi.nlm.nih.gov/pubmed/32355990
http://dx.doi.org/10.1007/s00228-020-02860-w

Ejemplares similares